Please login to the form below
1
Revenue 2017Humira
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humira was produced by AbbVie and Eisai.
European biosimilars hit AbbVie’s Humira revenues in Q4
Strong full year growth, but M&A speculation will linger. The launch of biosimilar versions of Humira saw revenues from the blockbuster drug grind to a halt in Q4. ... Nevertheless, the perilous transition away from Humira is leading many analysts to
Drug launches to watch in 2019
Humira reached revenues of around $20bn in 2018, meaning AbbVie will soon have a very large hole in its revenues to fill. ... its own TNF inhibitor Humira (adalimumab), currently the biggest-selling drug in the world with revenues of $16bn in 2017.
NHS England sees off AbbVie's Hep C legal challenge
Among these is another procurement drive where AbbVie has lost out – the recent launch of biosimilar versions of its inflammation blockbuster Humira (adalimumab). ... It says it believes patients who are stable on their biologic medicine should not be
BMS and Celgene deal sparks debate on pharma profit motive, more M&A
Despite a healthy looking pipeline, AbbVie will still struggle to replace its blockbuster Humira when it loses its US patent in 2023.
Generic Differentiation
The former is evidenced, most recently, by the biosimilars piling in the moment Humira loses protection.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
-
Senior Medical Writer
-
Great salary and benefits
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Digital Account Director
-
Salary TBC
-
Project Manager/ Account Manager
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
-
Senior Medical Writer
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
Subscribe to our email news alerts
- Drug launches to watch in 2019
- Welcome to the Communique Awards - Communiqué Awards 2018
- ‘Inflexible’ NICE blocking access to rare disease drugs
- GW Pharma's cannabis-based medicine to be tested in dementia
- Immuno-oncology in 2019: the rapid evolution continues
- 2019: CRISPR and therapeutic gene editing comes of age
- The importance of co-creation with patients
- McCann Health's next challenge: creative differentiation
- Greater Manchester backs move to outcome-based payment
- Merck & Co to buy IO specialists Immune Design for $300m
- More good news, and some bad, for Merck’s Keytruda
- Xencor’s Novartis-partnered bispecific on hold after patient deaths
PMHub
Apex.co.uk Conferences, Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...
Latest intelligence
- The importance of co-creation with patients
- Overcoming the barriers...
- Three billboards on the road to multichannel
- Chris Ross examines the trends driving multichannel communication in 2019...
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Quick links
Infographics
